From: BIGKnock: fine-mapping gene-based associations via knockoff analysis of biobank-scale data
BIGKnock locus-trait | position (hg19) | # GeneScan3D | # BIGKnock | BIGKnock genes |
---|---|---|---|---|
BRAP-CAD | 12: 111,986,818–112,986,818 | 12 | 3 | ALDH2, ATXN2, BRAP |
UBE2Z-Asthma | 17: 46,948,346–47,948,346 | 11 | 2 | NGFR, UBE2Z |
AGPAT1-T2D | 6: 32,126,272–33,126,272 | 12 | 1 | AGPAT1 |
CPEB3-T2D | 10: 93,966,910–94,966,910 | 6 | 2 | MARCHF5, CPEB3 |
IL2RA-Hypothyroidism | 10: 5,606,266–6,606,266 | 8 | 2 | GDI2, IL2RA |
CD69-Hypothyroidism | 12: 94,22,652–10,422,652 | 7 | 2 | CD69, CLEC2B |
HMGCR-Hyperlipidemia | 5: 74,105,220–75,105,220 | 7 | 1 | HMGCR |
BUD13-Hyperlipidemia | 11: 116,148,917–117,148,917 | 12 | 3 | APOA5, BUD13, ZNF259 |
ASGR1-Cholesterol | 17: 6,569,412–7,569,412 | 43 | 2 | ASGR1, CD68 |
SLC39A8-BP-Diastolic | 4: 103,269,304–104,269,304 | 6 | 1 | SLC39A8 |
DBH-BP-Diastolic | 9: 135,649,709–136,649,709 | 6 | 3 | ADAMTS13, DBH, SARDH |
ANGPTL4-Cholesterol | 19: 7,951,937–8,951,937 | 9 | 1 | ANGPTL4 |
RAB11A-Neutrophil count | 15: 65,544,465–66,544,465 | 8 | 1 | RAB11A |
ZHX3-Calcium | 20: 39,455,078–40,455,078 | 6 | 1 | ZHX3 |
PPARG-LDL cholesterol | 3: 11,739,931–12,739,931 | 6 | 1 | PPARG |
POLDIP2-LDL cholesterol | 17: 26,194,861–27,194,861 | 22 | 3 | POLDIP2, SLC13A2, TMEM199 |
E2F4-RBC count | 16: 66,229,250–67,229,250 | 18 | 3 | E2F4, FAM96B, KIAA0895L |
ENSA-WBC count | 1: 150,095,537–151,095,537 | 26 | 2 | ENSA, MCL1 |
E2F2-Lymphocyte count | 1: 23,019,508–24,019,508 | 11 | 1 | E2F2 |
KCTD17-Hematocrit percentage | 22: 36,962,936–37,962,936 | 11 | 3 | KCTD17, MPST, TMPRSS6 |
SAMD7-MCH | 3: 169,029,895–170,029,895 | 10 | 3 | ACTRT3, LRRC31, SAMD7 |
ITGA4-Monocyte percentage | 2: 182,392,917–183,392,917 | 6 | 3 | CERKL, ITGA4, NEUROD1 |